Difference in Control of Psychosis and Aggression for Patients Receiving the Maximum Dose of Haloperidol Decanoate Every Two Weeks Compared to Every Four Weeks, M Sherman, S Ungureanu, T Harrison, Stepan Uhlyar, Jose A. Rey
Faculty Proceedings, Presentations, Posters, Speeches, Lectures, etc.

Difference in Control of Psychosis and Aggression for Patients Receiving the Maximum Dose of Haloperidol Decanoate Every Two Weeks Compared to Every Four Weeks, M Sherman, S Ungureanu, T Harrison, Stepan Uhlyar, Jose A. Rey
Faculty Proceedings, Presentations, Posters, Speeches, Lectures, etc.

Difference in Control of Psychosis and Aggression for Patients Receiving the Maximum Dose of Haloperidol Decanoate Every Two Weeks Compared to Every Four Weeks, M Sherman, S Ungureanu, T Harrison, Stepan Uhlyar, Jose A. Rey
Faculty Proceedings, Presentations, Posters, Speeches, Lectures, etc.

A Retrospective Analysis of Single versus Combination Antipsychotic Treatment in a Long-Term Psychiatric Facility, Yesenia Sanin, Stepan Uhlyar, Jose A. Rey
Faculty Proceedings, Presentations, Posters, Speeches, Lectures, etc.

Impact of Metformin Utilization in Patient with Mental Health Disorders and Metabolic Syndrome, Stepan Uhlyar, Jose A. Rey
Faculty Proceedings, Presentations, Posters, Speeches, Lectures, etc.

Valbenazine (Ingrezza): The First FDA-Approved Treatment for Tardive Dyskinesia, Stepan Uhlyar, Jose A. Rey
Faculty Articles